Patrizia Falcone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Patrizia Falcone has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Rossella Fucci
Assited Reproductive Technology Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
2 shared publications - Asia Iserani
Department of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence, Florence, Italy
1 shared publication - Cristina Gonzalez-Navas
Ovobank (Egg Bank), Marbella, Málaga, Spain
1 shared publication - Daniel Fernando Sosa-Rosales
Ovobank (Egg Bank), Marbella, Málaga, Spain
1 shared publication - Denise De Angelis
Assited Reproductive Technology Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
1 shared publication - Enrique Criado-Scholz
Ovobank (Egg Bank), Marbella, Málaga, Spain
1 shared publication
Latest Publications
- Open Access
- 28 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (4) , 1331-1341
Application of a single “Universal warming protocol” for vitrified donor oocytes: A multicenter study
Purpose The objective of the multicenter study is to demonstrate the efficacy of the “Universal Warming Protocol (UWP)” using different devitrification media in donor oocytes that were previously vitrified in a single egg bank. Method A total of 2172 oocytes (metaphase II) were vitrified at Ovobank (Spain) using Kitazato vitrification media (Kitazato, Japan). The oocytes were devitrified at three different centers. Group A: 1021 oocytes devitrified with Kitazato media (Kitazato, Japan); Group B: 496 oocytes devitrified with Irvine media (Fujifilm Irvine Scientific, USA); Group C: 655 oocytes devitrified with RapidWarm Omni media (Vitrolife, Sweden). The study parameters included survival rate, fertilization rate, cleavage rate, blastulation rate, and a pregnancy rate confirmed by a biochemical test; transferring embryos at D + 3 and D + 5; and clinical pregnancy rate, transferring embryos at D + 3 and D + 5. Results The survival rate was statistically higher in Group C (94%) compared to Group A (86%) and Group B (85%) (P value < 0.01). There were no statistically significant differences in the remaining parameters: fertilization rate (A: 77%, B: 74%, C: 73%); cleavage rate (A: 83%, B: 83%, C: 80%); blastulation rate (A: 52%, B: 58%, C: 57%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 3 (A: 38%, B: 33%, C: 33%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 5 (A: 54%, B: 76%, C: 65%); clinical pregnancy rate in transferring embryos at D + 3 (A: 27%, B: 13%, C: 18%); clinical pregnancy rate in transferring embryos at D + 5 (A: 39%, B: 57%, C: 60%). Conclusions The idea that oocyte devitrification medium should always be from the same supplier is questionable. Therefore, it is feasible to use different devitrification media for donor oocytes that were vitrified with the same vitrification medium.
- 28 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (4) , 1331-1341
Open AccessApplication of a single “Universal warming protocol” for vitrified donor oocytes: A multicenter study
Purpose The objective of the multicenter study is to demonstrate the efficacy of the “Universal Warming Protocol (UWP)” using different devitrification media in donor oocytes that were previously vitrified in a single egg bank. Method A total of 2172 oocytes (metaphase II) were vitrified at Ovobank (Spain) using Kitazato vitrification media (Kitazato, Japan). The oocytes were devitrified at three different centers. Group A: 1021 oocytes devitrified with Kitazato media (Kitazato, Japan); Group B: 496 oocytes devitrified with Irvine media (Fujifilm Irvine Scientific, USA); Group C: 655 oocytes devitrified with RapidWarm Omni media (Vitrolife, Sweden). The study parameters included survival rate, fertilization rate, cleavage rate, blastulation rate, and a pregnancy rate confirmed by a biochemical test; transferring embryos at D + 3 and D + 5; and clinical pregnancy rate, transferring embryos at D + 3 and D + 5. Results The survival rate was statistically higher in Group C (94%) compared to Group A (86%) and Group B (85%) (P value < 0.01). There were no statistically significant differences in the remaining parameters: fertilization rate (A: 77%, B: 74%, C: 73%); cleavage rate (A: 83%, B: 83%, C: 80%); blastulation rate (A: 52%, B: 58%, C: 57%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 3 (A: 38%, B: 33%, C: 33%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 5 (A: 54%, B: 76%, C: 65%); clinical pregnancy rate in transferring embryos at D + 3 (A: 27%, B: 13%, C: 18%); clinical pregnancy rate in transferring embryos at D + 5 (A: 39%, B: 57%, C: 60%). Conclusions The idea that oocyte devitrification medium should always be from the same supplier is questionable. Therefore, it is feasible to use different devitrification media for donor oocytes that were vitrified with the same vitrification medium.